Post by Eurofins

Microplastics enter the U.S. regulatory spotlight 🔬 On April 2nd, 2026, the U.S Environmental Protection Agency (EPA) and the Department of Health and Human Services (HHS) announced coordinated actions to address the growing public health concerns surrounding microplastics. For the first time, the EPA has included microplastics as a priority contaminant group in the sixth proposed edition of the Contaminant Candidate List (CCL 6), a key element of the Safe Drinking Water Act (SDWA). In tandem, the Advanced Research Projects Agency for Health (ARPA-H) launched its ‘Systematic Targeting of Microplastics’ (STOMP) initiative, a groundbreaking national programme focused on: • Measuring microplastics in water and human tissue • Identifying the most harmful plastics and exposure pathways • Future efforts for developing methods to remove microplastics from the human body Together, these actions represent the most comprehensive effort in the USA to date to understand and address microplastics across both environmental and human health indices – a clear indication that microplastics have transcended an emerging issue and become a regulatory priority. The Eurofins network of Environment Testing laboratories is uniquely positioned to navigate this dynamic regulatory landscape, operating six specialised microplastics facilities across Europe, America, Asia and Oceania that are equipped with state‑of‑the‑art instrumentation. These expert-led laboratories offer a comprehensive suite of microplastics detection and quantification services, leveraging cutting-edge analytical techniques to provide robust, reliable results to clients worldwide. Learn more about Eurofins Environment Testing's microplastics services here: https://lnkd.in/eQ6s9WXv